- Home
- RBOT
as 10-17-2024 4:00pm EST
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
| Founded: | 2014 | Country: | United States |
| Employees: | 131 | City: | WALTHAM |
| Market Cap: | 48.2M | IPO Year: | N/A |
| Target Price: | $11.33 | AVG Volume (30 days): | 21.2K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.27 - $21.42 | Next Earning Date: | 11-11-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vicarious Surgical Inc. News
RBOT Breaking Stock News: Dive into RBOT Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Business Wire
2 months ago
Vicarious Surgical Reports Second Quarter 2024 Financial Results
Business Wire
2 months ago
Vicarious Surgical Announces New Hospital System Partnership with LSU Health New Orleans
Business Wire
3 months ago
Vicarious Surgical to Report Second Quarter 2024 Financial Results on August 12, 2024
Simply Wall St.
4 months ago
Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Business Wire
4 months ago
Vicarious Surgical Announces Reverse Stock Split
GuruFocus.com
6 months ago
Vicarious Surgical Inc (RBOT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Cost ...
Business Wire
6 months ago
Vicarious Surgical Reports First Quarter 2024 Financial Results
Compare RBOT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RBOT Vicarious Surgical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.